03/03/2020 12:00 AM EST
Source: U.S. Senate, Committee on Health, Education, Labor, and Pensions. Published: 3/3/2020. This two-hour, 45-minute Congressional hearing features representatives of the Department of Health and Human Services who detail how HHS programs are responding to COVID-19 (coronavirus disease) by working to prevent and slow the spread of the disease; assist repatriated Americans; protect the supply of food, drugs, and devices; and develop diagnostics, therapeutics, and vaccines. Topics include the Biomedical Advanced Research and Development Authority (BARDA), which is working across the U.S. Government to assess and identify potential partners and technologies suitable to address the COVID-19 outbreak–both for prevention and treatment. (Video or Multimedia)
03/02/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/2/2020. This guidance provides recommendations on the routine cleaning and disinfection of polling location areas and associated electronic equipment (e.g., voting machines and computers). It suggests actions that polling station workers can take for themselves and the general public to reduce the risk of exposure to COVID-19 (coronavirus disease) by limiting the survival of the virus in the environment. (Text)
03/02/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 3/2/2020. The risk associated with COVID-19 (coronavirus disease) infection for people in the European Union/European Economic Area (EU/EEA) and United Kingdom (UK) is currently considered to be moderate to high, based on the probability of transmission and the impact of the disease. This 29-page report details the risk to the healthcare systems in the EU/EEA and the UK; risk of widespread and sustained transmission in the EU/EEA and UK in the coming weeks; and options for preparedness and response, including a proposed change in the case definition and the integration of testing for COVID-19 in surveillance systems for influenza surveillance (ARI/ILI) and severe acute respiratory infections. (PDF)
03/02/2020 12:00 AM EST
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 3/2/2020. This 11-page checklist identifies specific activities that a jurisdiction can do now to prepare for, respond to, and be resilient in the face of COVID-19 (coronavirus disease). Many of the activities in this checklist are specific for COVID-19; however, many pertain to any public health emergency. The checklist lists Safety/Infection Control Activities; EMS Activities; and Hospitals and Health Care Activities. (PDF)
03/02/2020 12:00 AM EST
Source: Harvard University, Harvard T.H. Chan School of Public Health. Published: 3/2/2020. This one-hour, 14-minute panel discussion examines pressing questions about the coronavirus disease (COVID-19) outbreak, including: What do we know about the virus itself? How likely is a future vaccine? How is China’s stressed health system coping, and how are U.S. hospital systems preparing for cases? What happens if COVID-19 emerges forcefully in areas of the world lacking infrastructure, and what does an effective global response look like? (Video or Multimedia)
03/01/2020 12:00 AM EST
Source: National Child Traumatic Stress Network (NCTSN). Published: 3/1/2020. This five-page document provides information for parents and caregivers about infectious disease outbreaks, including coronavirus disease (COVID-19), in the community. Knowing important information about the outbreak and learning how to be prepared can reduce stress and help calm likely anxieties. This resource will help parents and caregivers think about how an infectious disease outbreak might affect their family— both physically and emotionally—and what they can do to help their family cope. (PDF)
03/01/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/1/2020. This web page provides general strategies that the Centers for Disease Control and Prevention (CDC) recommends to prevent the spread of COVID-19 (coronavirus disease) in long-term care facilities to prevent the introduction of respiratory germs INTO a facility; prevent the spread of respiratory germs WITHIN a facility; and prevent the spread of respiratory germs BETWEEN facilities. (Text)
02/29/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/29/2020. The true impact of a COVID-19 (coronavirus disease) outbreak in a U.S. community cannot be predicted. However, all healthcare facilities can take the steps on this web page now to prepare for such an outbreak, communicate with patients and staff, and protect patients and staff. (Text)
02/29/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/29/2020. This interim guidance outlines goals and strategies for all U.S. healthcare facilities to prepare for and respond to community spread of coronavirus disease-2019 (COVID-19). It details actions to take if COVID-19 is spreading in the community; considerations for specific settings; and shifting healthcare delivery modes during a COVID-19 outbreak in the United States. (Text)
02/29/2020 12:00 AM EST
Source: U.S. Food and Drug Administration (FDA). Published: 2/29/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel. The New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel is authorized for use on respiratory specimens from individuals who meet the Centers for Disease Control and Prevention (CDC) coronavirus disease 2019 (COVID-19) clinical and/or epidemiological criteria. (PDF)
02/28/2020 12:00 AM EST
Source: United Kingdom Department of Health (DH). Published: 2/28/2020. This page, updated on February 28, 2020, provides resources and guidance for schools and other educational settings in providing advice about the 2019 novel coronavirus (COVID-19). It discusses how to help prevent spread of all respiratory infections including COVID-19; what to do if someone confirmed or suspected to have COVID-19 has been in a school or other educational setting; and what advice to give to individuals who have traveled to specified countries and areas within the last 14 days. (Text)
02/28/2020 12:00 AM EST
Source: evaplan GmbH [University Hospital Heidelberg]. Published: 2/28/2020. This 78-page report provides information about population surveys of three neighboring European Union countries (Georgia, Israel, and Tunisia) that do not have risk community strategies for heatwaves. The aim of the surveys was to to measure the current risk perceptions of heatwaves, people's sensitivity, their knowledge levels regarding risk groups, protective measures and symptoms, and information sources. (PDF)
02/28/2020 12:00 AM EST
Source: Public Health Agency of Canada (PHAC). Published: 2/28/2020. This guidance for federal/provincial/territorial public health authorities on the prevention and management of novel coronavirus (COVID-19) in schools and childcare settings outlines a strategy of containment (i.e., to reduce opportunities for transmission to contacts in the community). It is based on the Canadian context and public health assumptions that reflect the currently available scientific evidence and expert opinion. (Text)
02/27/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/27/2020. This electronic version of the Model List of Essential Medicines (known as eEML) was launched in a Beta Phase on February 27, 2020. It is a comprehensive, freely accessible, online database containing information on essential medicines, and found 1,092 recommendations for 554 medicines and 44 therapeutic equivalents. (Text)
02/27/2020 12:00 AM EST
Source: Public Health Agency of Canada (PHAC). Published: 2/27/2020. In order to develop technical guidance to support federal/provincial/territorial public health authorities and front-line clinicians in health care settings to respond to the novel coronavirus causing COVID-19, the assumptions on this web page were taken to develop interim guidance documents. These assumptions are based on currently available scientific evidence and expert opinion and are subject to change as new information on transmissibility and epidemiology becomes available. (Text)
02/24/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/24/2020. This 68-page protocol is a multi-center, adaptive, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of investigational therapeutic agents in combination with standard-of-care for the treatment of hospitalized patients with novel coronavirus disease (COVID-19). It describes a study that is a multi-center trial that will be conducted in up to 50 sites globally with multiple sponsors. Using a Master Protocol can speed the implementation of clinical trials. (PDF)
02/14/2020 12:00 AM EST
Source: American Society of Health-Systems Pharmacists (ASHP). Published: 2/14/2020. This web page provides a sample list of potential pharmacy public health roles at the local or state levels, including for COVID-19 (coronavirus disease). The table provides information about Preparation Category, Prepare For, Cause, and Issues. (Text)
02/13/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/13/2020. To support countries’ preparedness effort on the COVID-19 (coronavirus) outbreak, the World Health Organization`s Department of Health Security and Preparedness has developed this generic COVID-19 tabletop exercise package. The exercise aims to examine and strengthen existing plans, procedures, and capabilities to manage an imported case of COVID-19, and targets health authorities at the national level. (Text)
02/12/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/12/2020. This seven-page report summarizes a meeting of world experts on COVID-19 held on February 11-12, 2020, to assess the current level of knowledge about the coronavirus, agree on critical research questions that need to be answered urgently, and find ways to work together to accelerate and fund priority research that can contribute to curtail this outbreak and prepare for future outbreaks. The report details eight immediate research actions were agreed upon as part of this forum. (PDF)
02/01/2020 12:00 AM EST
Source: U.S. Department of Homeland Security (DHS). Published: 2/2020. This 34-page guide defines actions that management and staff at healthcare facilities can take to understand and improve their ability to perform counter-improvised explosive device (C-IED) activities and make security decisions. It is designed to provide personnel at healthcare facilities with a practical framework to examine their ability to perform C-IED activities, and supporting guidance and materials to strengthen their C-IED preparedness. (PDF)
.png)
No hay comentarios:
Publicar un comentario